Mesna (Mesnex) — Clinical FAQs

Question 1

What is Mesna FDA-approved to treat?

Accepted Answer

Mesna is FDA-approved for the following oncology indications: 1. Prophylaxis of ifosfamide-induced hemorrhagic cystitis (required with all ifosfamide-containing regimens) 2. Prophylaxis of high-dose cyclophosphamide-induced hemorrhagic cystitis (typically required for IV doses ≥1 g/m²; standard in transplant conditioning regimens).

Question 2

How does Mesna work (mechanism of action)?

Accepted Answer

Synthetic sulfhydryl uroprotectant (sodium 2-mercaptoethane sulfonate). After IV administration, mesna circulates in the oxidized disulfide form (dimesna) in the bloodstream. In the renal tubule, dimesna is reduced back to active free mesna (containing a free thiol —SH group). Mesna in the urine irreversibly binds to and inactivates acrolein — the principal urotoxic metabolite of ifosfamide and high-dose cyclophosphamide that causes hemorrhagic cystitis. Acrolein, formed by hepatic metabolism of oxazaphosphorine alkylating agents, is excreted in urine where it damages the urothelium (bladder, ureter, renal pelvis). Mesna's thiol group neutralizes acrolein and 4-hydroxy metabolites through a Michael addition reaction, preventing urothelial injury. Mesna acts exclusively in the urinary tract and does NOT alter the systemic anti-tumor activity of ifosfamide or cyclophosphamide.

Question 3

How is Mesna administered?

Accepted Answer

Mesna is administered Intravenous (IV) or Oral (PO). IV protocol (most reliable): mesna 20% of ifosfamide dose at time 0 h (concurrent with ifosfamide), then at 4 h and 8 h after each ifosfamide dose (total mesna dose = 60% of ifosfamide dose).

Question 4

What are the most common side effects of Mesna?

Accepted Answer

The most commonly reported side effects of Mesna (≥10% incidence) include: Nausea and vomiting (particularly with oral formulation), Headache, Diarrhea, Limb pain, Injection site reactions (IV) and others (7 total). Consult your oncologist for complete prescribing information.

Question 5

Is Mesna safe during pregnancy?

Accepted Answer

Mesna pregnancy safety: Category B — reproductive studies in animals did not demonstrate fetal harm; no adequate well-controlled studies in pregnant women. Use when clearly needed.. Oncologists should review the complete prescribing information and discuss reproductive risks with patients before initiating therapy.

Mesna — Drug Monograph

Mechanism of Action

FDA Indications

Common Side Effects

Clinical Pearl

Related Therapies & Mechanisms